Functional Restoration of Pituitary after Pituitary Allotransplantation into Hypophysectomized Rats by 김세훈
cells
Article
Functional Restoration of Pituitary after Pituitary
Allotransplantation into Hypophysectomized Rats
Jai Ho Choi 1,† , Jung Eun Lee 2,†, Hong-Lim Kim 3, Seung Hyun Ko 4, Se Hoon Kim 5 and Seung Ho Yang 2,*


Citation: Choi, J.H.; Lee, J.E.; Kim,
H.-L.; Ko, S.H.; Kim, S.H.; Yang, S.H.
Functional Restoration of Pituitary
after Pituitary Allotransplantation
into Hypophysectomized Rats. Cells
2021, 10, 267. https://doi.org/
10.3390/cells10020267
Received: 28 December 2020
Accepted: 25 January 2021
Published: 29 January 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of Neurosurgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University
of Korea, 222 Banpodaero, Seochogu, Seoul 06591, Korea; bivalvia@catholic.ac.kr
2 Cell Death Disease Research Center, Department of Neurosurgery, St. Vincent Hospital, College of Medicine,
The Catholic University of Korea, 222 Banpodaero, Seochogu, Seoul 06591, Korea; eunree@nate.com
3 Integrative Research Support Center, Laboratory of Electron Microscope, College of Medicine, The Catholic
University of Korea, 222 Banpodaero, Seochogu, Seoul 06591, Korea; wgwkim@catholic.ac.kr
4 Department of Endocrinology, St. Vincent Hospital, College of Medicine, The Catholic University of Korea,
222 Banpodaero, Seochogu, Seoul 06591, Korea; kosh@catholic.ac.kr
5 Department of Pathology, Yonsei University of College of Medicine, Seochogu, Seoul 06591, Korea;
paxco@yuhs.ac
* Correspondence: 72ysh@catholic.ac.kr; Tel.: +82-31-881-8962
† These authors contributed equally to this work.
Abstract: Long-term hormone replacement therapy due to panhypopituitarism can lead to serious
complications and thus, pituitary transplantation is considered a more desirable. We investigated
functional restoration after allotransplatation of the pituitary gland. We transplanted extracted
pituitary gland into the omentum of an hypophysectomized rat. Two experiments were performed:
(1) to confirm the hypophysectomy was successful and (2) to assess functional restoration after
pituitary transplantation. Pituitary hormone level and weight change were consecutively assessed.
Electron microscopic (EM) examinations were performed to identify morphological changes at 3 days
after transplantation. We confirmed that pituitary gland was properly extracted from 6 rats after
sacrifice. The findings showed (1) a weight loss of more than 3% or (2) a weight change of less
than 2% along with a decreased growth hormone (GH) level by more than 80% at 2 weeks post-
hypophysectomy. A further four rats underwent pituitary transplantation after hypophysectomy
and were compared with the previously hypophysectomized rats. All showed rapid weight gain
during the two weeks after transplantation. The thyroid-stimulating hormone, prolactin, and GH
levels were restored at one week post-transplantation and maintained for 10 weeks. Hypophyseal
tissue architecture was maintained at 3 days after transplantation, as indicated by EM. These data
suggest that a transplanted pituitary gland can survive in the omentum with concomitant partial
restoration of anterior pituitary hormones.
Keywords: pituitary gland; transplantation; hypophysectomy
1. Introduction
The endocrine system is regulated by the hypothalamic-pituitary-organ axis (HPA).
The hypothalamus delivers precise signals to the pituitary gland. Various hormones are
then released from the pituitary gland to stimulate and regulate target organs including
the thyroid gland, adrenal gland, and gonads. Pituitary hormones are also associated
with growth, lactation, and water balance. Consequently, the pituitary gland is the main
regulator of the endocrine system [1]. Deterioration of pituitary functions can lead to seri-
ous complications including diabetes insipidus, hypothyroidism and hypocortisolemia [2].
Lifelong hormonal replacement therapy is needed in these patients, but significant adverse
effects can develop through the use of a long-term hormonal replacement [3].
Organ transplantation remains the most effective treatment for end-stage organ failure,
not only in most vascularized solid organs such as the liver, kidneys, heart, and lungs but
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also in non-vascularized islet cell transplantation for the treatment of diabetes mellitus,
even though transplantation has some limitations including graft failure or rejection, histo-
compatibility, the use of immunosuppressants, and the long-term survival of implanted
organs [4,5]. Although advances in knowledge and technique continue to improve the
clinical outcomes of solid and tissue transplantation, clinical application to the pituitary
gland has been limited [6].
Harvey Cushing inceptively attempted pituitary transplantation on a human patient
in 1908 [6]. Since Cushing’s pioneering attempt, several researchers have investigated
experimental pituitary transplantation [7–10]. Pituitary grafting to reveal the hypotha-
lamic control of the pituitary gland was studied by Harris and Jacobshon in 1952 [8].
Halasz et al. suggested the term “hypophysiotrophic area” to support pituitary transplanta-
tion in 1962 [11]. The first experimental pituitary transplantation into various hypothalamic
regions of hypophysectomized rats was conducted by Knigge et al. in 1962 [9]. In 1985, Tuli-
pan et al. (reinforced by Maxwell et al. in 1998) demonstrated the restoration of pituitary
hormones in plasma after pituitary transplantation into hypophysectomized rats [7,12].
However, further investigations regarding pituitary transplantation for functional restora-
tion of pituitary hormones have rarely been performed since 1998. Pituitary transplantation
can be used as a theoretical curable method for hypopituitarism to physiologically over-
come the side effects of long-term hormonal replacement therapy.
In this study, we investigated the functional restoration of pituitary hormones after
allotransplantation of the pituitary gland into omental pouches of hypophysectomized rats
with severe combined immunodeficiency (SCID).
2. Materials and Methods
2.1. Animals
Male SCID Sprague Dawley rats weighing 160–280 g (Koatech, Pyungtaek, Korea)
were used in this study. These animals were housed in a laboratory with a controlled
temperature and a 12 h light-dark cycle. Food and water were provided ad libitum. All
protocols regarding the use of animals were approved by the Institutional Animal Care
and Use Committees (IACUC) of the Catholic University of Korea (SVH IRB 17-5). All
experiments were carried out in accordance with the relevant guidelines and regulations.
2.2. Parapharyngeal Approach to Remove the Pituitary Gland
All SCID rats were anesthetized with gas anesthesia (3% isoflurane in 500 mL/min O2).
Surgeries were performed as described previously [13]. Briefly, we made a skin incision
on the midline of the anterior neck and entered into the floor of the cranium through the
omohyoid muscle located at the lower edge of the sternohyoid muscle. After the retraction
of the sternohyoid muscle, trachea, and esophagus laterally, the cranial bone was vertically
drilled out at the midline and in front of the blue suture line with the bone burr under a
binocular microscope. The last layer of cranial bone was broken off as a circular piece. The
hole was widened until most of the underlying pituitary gland was exposed. We obtained
the pituitary gland with a fine membrane using fine forceps.
2.3. Experiments to Determine Correct Removal of the Pituitary Gland
For assessing whether the pituitary gland was properly removed or not, 10 SCID rats
were used. After removal of the pituitary gland, we sequentially checked serum levels of
pituitary hormones including thyroid stimulating hormone (TSH), growth hormone (GH),
prolactin, and adrenocorticotropic hormone (ACTH) using enzyme linked immunosorbent
assays (ELISA) and weight change to confirm the appropriate hypophysectomy procedure
had been performed. Rat serum was regularly obtained from the tail vein at 10 a.m. We
examined serum hormone level before surgery and at 2, 4, 6, 8, 10, 12 and 14 weeks after
surgery. Body weight was also examined before surgery and at 2, 4, 6, 8, 10, 12 and
14 weeks after surgery. After completion of the experiment schedules, rats were sacrificed,
and the sellar region was examined to determine whether the hypophysectomy had been
Cells 2021, 10, 267 3 of 11
performed correctly. The cranial vault was removed and the right hemisphere was retracted.
The midline skull base structure was examined with a binocular microscope to determine
whether the pituitary gland remained.
2.4. Pituitary Gland Transplantation into the Omentum and the Follow-Up Protocol
For identifying whether the pituitary function could be restored after transplantation,
another 4 SCID rats were used. All rats were anesthetized using gas anesthesia (3%
isoflurane in 500 mL/min O2) and placed in a supine position. The pituitary gland was
extracted from a sibling male rat and stored in histidine-tryptophan-ketoglutarate (HTK)
solution. For the transplantation procedure, the abdominal area was shaved and sterilized
using povidone iodine. A laparotomy procedure of approximately 2 cm was done and the
omentum was pulled out. The pituitary gland of the donor was placed on the omentum
and packed in scaffold form (Figure 1). The graft was put back into the abdominal cavity.
The peritoneum and skin were closed layer-by-layer.
Figure 1. The extracted pituitary gland (white arrow) was placed on the omentum (black arrow).
Thereafter, the gland was packed within the omental pouch (black arrowhead).
Serum levels of hormones, including TSH, GH, prolactin, and ACTH, from the tail
vein were examined sequentially using ELISA. Hormone levels and body weight at baseline
and at 2 weeks after hypophysectomy were evaluated to confirm the hypophysectomy was
performed correctly. We transplanted the extracted pituitary gland from another SCID rat
into the omental pouch of a hypophysectomized rat at three weeks after hypophysectomy.
Serum hormone levels and body weight were obtained sequentially once every 2 weeks
after pituitary transplantation. Details of the study protocol are illustrated in Figure 2. The
serum hormone levels and body weights of the transplanted group were compared to those
of the hypophysectomy group.
Figure 2. The study protocol for assessing hormonal and body weight change after pituitary transplantation into the
omentum of an hypophysectomized rat.
2.5. Electron Microscopic and Immunohistochemical Examination after Pituitary Transplantation
The implanted pituitary gland was harvested at 3 days after transplantation and
assessed by electron microscopy (EM, JEM-1010, Jeol, Japan). Ultrastructural changes
including nucleus degeneration, and damage to the mitochondria, rough endoplasmic
reticulum (RER), and secretory granules (SGs) were evaluated. Details of tissue preparation
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are described in our previous report [13]. Briefly, the tissue was placed in a fixative, washed
with phosphate buffer saline (PBS), and post-fixed in phosphate-buffered 1% osmium
tetroxide. After dehydration with alcohol, the tissue was embedded in an EPON resin.
Ultrathin sections (70–80 nm in thickness) were made with an ultramicrotome (Ultracut
UCT, Leica, Austria) and subsequently stained with uranyl acetate and lead citrate.
For histopathologic examination, the extracted pituitary glands were fixed in 10%
formalin and embedded in paraffin. Sequential sections of the pituitary gland were cut
to 4 µm thickness with a cryostat and mounted onto slides. After deparaffinization and
rehydration with xylene, ethanol, and deionized H2O, these sections were stained with
hematoxylin and eosin (H&E). In addition, special staining for detecting ACTH, GH,
prolactin, and TSH was conducted.
3. Results
3.1. Serum Hormone Levels and Body Weight Change after Appropriate Hypophysectomy
We performed hypophysectomy for a total of 10 SCID rats to identify a correct hy-
pophysectomy. Of these ten rats, six were found to have undergone adequate pituitary
gland removal (more than 70%) on microscopic examination after sacrifice and surgery
(Figure 3). One rat showed 6.8% weight loss at two weeks after the hypophysectomy and
died a few days later. Five out of the six rats showed (1) weight loss of more than 3% or
(2) a weight change of less than 2% along with a decreased serum GH level by more than
80% at two weeks post-hypophysectomy. Details regarding hormone levels and weight
change of properly hypophysectomized rats are depicted in Figure 4. Serum TSH levels
gradually decreased after surgery and were not detected at 4–6 weeks after surgery. Serum
GH and prolactin levels abruptly decreased two weeks postoperation. This was maintained
until 6–8 weeks and disappeared at 10 weeks. Serum ACTH levels were maintained until
4–6 weeks after surgery and sharply dropped at 6–8 weeks postoperation. The body weight
of adequately hypophysectomized rats showed almost no change until 14 weeks after
surgery. In contrast, all rats (n = 4) with inadequate removal of the pituitary gland showed
(1) gradual weight gain or (2) no change in serum hormone levels.
Figure 3. (A) Adequate removal of pituitary gland. A small remnant of the pituitary gland (black
arrow) was shown in the sellar fossa on microscopic examination. (B) In contrast, large amounts
of remnant pituitary gland (white arrow) were shown in cases with inadequate removal of the
pituitary gland.
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Figure 4. Serum hormone changes of five rats with adequate removal of the pituitary gland over time. The serum TSH level
gradually decreased. It was not detected at 4–6 weeks postoperation. Serum GH and prolactin levels abruptly decreased at
two weeks postoperation and were maintained until 6–8 weeks. Serum ACTH levels were maintained until 4–6 weeks and
sharply dropped 6–8 weeks postoperation. The body weights of correctly hypophysectomized rats seldom changed until
14 weeks. POD, postoperative day.
3.2. Serum Hormone Levels and Body Weight Change after Transplantation
Another four SCID rats were used to assess serum hormone and body weight change
after transplantation. These rats underwent pituitary transplantation into the omental
pouch three weeks after hypophysectomy. Serum TSH and GH levels decreased by more
than 80% compared to baseline hormone levels (less than 1.0 ng/mL in serum level) in all
rats at two weeks post-hypophysectomy. In addition, all hypophysectomized rats showed
no weight gain for two weeks. After pituitary transplantation, serum TSH levels were
elevated up to the baseline level at one week post-transplantation and maintained until
11 weeks after transplantation. Serum GH and prolactin levels normalized at one week
after transplantation but decreased thereafter over time. Serum ACTH levels gradually
decreased after hypophysectomy and were not detected at eight weeks posthypophysec-
tomy. Accordingly, pituitary transplantation did not affect the restoration of serum ACTH
(Figure 5). All rats after receiving pituitary transplantation showed rapid weight gain until
one week (246.4 ± 4.8 g) compared to baseline (167 ± 7.9 g) and gradually gained weight
until 11 weeks (295 ± 4.5 g at 11 weeks) after transplantation. In contrast, hypophysec-
tomized rats without transplantation (control group) showed no hormonal restoration or
weight gain (Figure 6). Mean TSH levels in the transplantation group (4.302 ± 0.664 ng/mL)
were significantly higher compared to the control group (0.018 ± 0.040 ng/mL, p = 0.001)
at one week after transplantation and maintained until 11 weeks after transplantation
(4.730 ± 0.991 versus 0 ng/mL at 11 weeks, p < 0.001). Serum GH (14.616 ± 6.176 versus
0.664 ± 0.426 ng/mL, p = 0.001) and prolactin (10.405 ± 1.786 versus 0.13 ± 0.241 ng/mL,
p < 0.001) levels were significantly different between the two groups at one week post-
transplantation but the difference gradually decreased. Mean serum GH levels were higher
in the transplantation group until 11 weeks, but there was no significant difference from
three weeks (7.715 ± 9.923 versus 0.696 ± 0.693 ng/mL, p = 0.152) after transplantation.
The statistical difference of serum prolactin levels was maintained until seven weeks
(4.765 ± 0.544 versus 0 ng/mL, p < 0.001) after transplantation. Serum ACTH levels did
not show a statistical difference between the two groups. Body weight was significantly
different between the two groups from five weeks (276.875 ± 8.035 versus 214.4 ± 43.281 g,
p = 0.034) after transplantation and was maintained until 11 weeks (295 ± 4.545 versus
220.5 ± 29.894 g at 11 weeks, p = 0.023) after transplantation (Figure 6).
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Figure 5. Serum hormone changes of four rats after hypophysectomy and pituitary transplantation. The serum TSH
level was elevated up to the baseline level at post-transplantation 1 week and maintained until 11 weeks after trans-
plantation. Serum GH and prolactin levels normalized at 1 week after transplantation but decreased over time. Serum
ACTH level gradually decreased after hypophysectomy and was not detected at 14 weeks post-hypophysectomy. POD,
postoperative day.
Figure 6. Mean TSH levels after transplantation were significantly higher compared to the hypophysectomy-only group and
maintained until 11 weeks after transplantation. Serum GH and prolatin levels normalized at 1 week after transplantation
and mean GH levels were significantly higher in the transplantation group than in the hypophysectomy-only group. There
was no significant difference in the mean ACTH levels between the two groups. Mean body weight was significantly
different between the two groups from 8 weeks posthypophysectomy. POD, postoperative day; * p < 0.05.
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3.3. Immunohistochemical Staining Results and Ultrastructural Changes on Electron Microscopic
Examination of Transplanted Pituitary Glands
The harvested pituitary glands from the omental pouches at three days after trans-
plantation maintained nearly normal ultrastructure on EM examination. Structures of
mitochondria, RER, and nuclei of harvested pituitary glands were maintained similarly to
those of the normal gland. The number and structure of SG were also retained. However,
small necrotic areas were found in the harvested pituitary glands. In addition, immunohis-
tochemical staining was done using harvested pituitary glands. We found well-preserved
adeno- and neuro-hypophysis in the H&E stain. Normal glandular structures with a nor-
mal number of acidophils and basophils and without ischemic foci were seen in anterior
hypophysis. Pituitary cells secreting ACTH, GH and prolactin showed strong positive
staining, but TSH showed relatively weak staining in immune staining (Figure 7)
Figure 7. H&E stain showing well-preserved adeno- and neuro-hypophysis at 3 days after transplantation. Special
immunohistochemical study showing strong positive staining for ACTH, prolactin, and GH. However, TSH showing
relatively weak staining on ImmunoHistoChemistry IHC examination. (Original magnification ×200). EM examination
of the harvested pituitary gland from the omental pouch at 3 days after transplantation. EM examination showed nearly
normal ultrastructure except small necrotic areas (black arrow). (original magnification ×1500) Structures of mitochondria,
RER, and nucleus were maintained similar to those of the normal gland. The number and structure of SGs were also
retained. (original magnification ×6000).
4. Discussion
The present study revealed that adequately hypophysectomized rats showed weight
loss or little weight gain along with decreased serum TSH and GH levels over time.
In contrast, rats with inadequate removal of the hypophysis gained weight based on a
normal growth curve. Previous studies have also suggested that no weight gain is an
important parameter for the correct hypophysectomy of rats [10,14,15]. In this study, we
additionally inspected the sellar region by binocular microscopy to confirm whether the
pituitary gland was properly removed after rat sacrifice. In rats with no weight gain
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or minimal weight gain, more than 70% of the total volume of the pituitary gland was
removed. Our results verify that weight loss or minimal weight gain is a very important
sign of adequate hypophysectomy. In this study, total hypophysectomy was impossible
because rats with total resection of hypophysis showed severe weight loss (more than 6%
of baseline weight) and quickly died after surgery. In this study, persistent circulating
ACTH for more than 4 weeks after hypophysectomy was found, even though the half-life
of pituitary hormones is short. This may be due to a substantial remaining portion of the
pituitary gland. However, other hormones (TSH, GH, and prolactin) rapidly decreased
at 2–4 weeks after hypophysectomy and this could be due to the functional decline of
the remaining pituitary tissue over time. Therefore, we performed transplantation at
3 weeks after hypophysectomy to minimize the influence of remaining pituitary tissue on
the restoration of hormones after pituitary implantation.
This study also identified that some hormone levels were restored, and body weight
was gained after pituitary transplantation. In 1980, Knigge et al. demonstrated that pi-
tuitary transplantation resulted in weight gain in all hypophysectomized rats [10]. They
suggested that total body weight was a parameter of implant survival. The return of
adrenal weight and sexual function and testicular maintenance after transplantation were
also reported in their study [10]. Tulipan et al. were the first investigators to show the
restoration of serum pituitary hormone levels, including prolactin and thyroxin after
hypophyseal implant [12]. Maxwell et al. then evaluated graft survival and functional
restoration by radioimmunoassay for serum pituitary hormone levels and also by correla-
tive immunohistochemistry in 1998 [7]. Their assay results revealed that serum levels of
hormones including prolactin, β-endorphin, GH, TSH, and luteinizing hormone (LH) were
restored in many of the rats with pituitary transplantation (45–100%), and reinforced by
immunohistochemical staining of the anterior lobe of the implanted gland [7]. Our results
also revealed the restitution of serum TSH, prolactin and GH levels after transplantation.
This was corroborated by EM examination. We assessed ultrastructural preservation of the
graft by EM at 3 days after transplantation. We have previously reported that the extracted
rat pituitary gland can be preserved for 3 days in HTK solution under hypothermic condi-
tions [13]. Therefore, we conducted EM examination to compare with the EM results of our
previous study. The ultrastructure of the transplanted pituitary gland in this study was
more preserved than the extracted gland preserved in the HTK solution. We additionally
conducted an IHC stain to evaluate the viability of a subtype of hormone-secreting cells.
Positive staining of hormone-secreting cells (ATCH, TSH, prolactin, and GH) can represent
functional preservation of implanted pituitary glands in this study.
In this study, we transplanted extracted pituitary gland into the omental pouch
of the abdominal cavity of rats. There is no general consensus on the optimal site of
pituitary transplantation. Commonly used sites for rat pituitary graft are the kidney
capsule (ectopic area), the hypophysiotropic area and the third ventricle [7,9–12,16–20].
The kidney capsule was regarded as the most convenient area for ectopic transplantation
of the pituitary gland [16–18]. The ectopic transplantation induced hyperprolactinemia
and nearly influenced other anterior pituitary functions in some earlier studies [21]. In
addition, such induced hyperprolactinemia can lead to several complications [22,23].
A key regulator of pituitary biology is the hypothalamic–pituitary relationship con-
nected with the specialized portal system delivering hypothalamic factors to the pituitary
gland. Hypothalamic input and pituitary feedback can be essential for maintaining physi-
ological levels and patterns of pituitary hormones. The pituitary fossa may be the most
important physiological site for pituitary transplantation along with specialized blood sup-
ply. However, the orthotopic transplantation of pituitary gland in rats was technically very
difficult in our preliminary experiments. Pituitary transplantation to the third ventricle has
been investigated by some investigators. Knigge et al. have suggested that cerebrospinal
fluid (CSF) hormonal flow might be a postulated hypothalamic–pituitary control pathway.
Accordingly, vascular input from portal vessels might not be a requisite for pituitary func-
tion [10]. Maxwell et al. have supported this hypothesis by performing a provocation test
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with exogenous hypothalamic releasing factors on rats with pituitary implant to the third
ventricle [7]. Therefore, the third ventricle can be considered a physiological and desirable
site for pituitary transplantation. However, in our preliminary experiments, we could not
find the implanted pituitary gland in the third ventricle after a few days, in contrast to the
previous study by Maxwell et al. This might have been due to the CSF circulation.
The omental pouch is widely used for pancreatic islet transplantation [24,25]. The
use of the omental pouch as a transplantation site has some advantages, as follows: (1)
a larger volume of tissues can be accommodated, (2) it can be more suitable for encap-
sulated or islet grafts with a low degree of endocrine cells, (3) secreted hormones can be
delivered to systemic circulation through hepatic portal system, and (4) the implanted
graft can be harvested at the end of study [24]. We could not find revascularization of
transplanted pituitary gland at 3 days after transplantation. Moreover, long-term survival
of transplanted glands without revascularization is a main drawback of pituitary transplan-
tation into the omental pouch. We tried to find implanted pituitary glands at seven days
after transplantation, but remaining glands could not be found in the omental pouch. In
contrast, implanted pituitary glands beneath the kidney capsule can be preserved for more
than eight weeks [16]. However, some reports have suggested that the omentum shows
the potential for angiogenesis to promote neovascularization in ischemic tissues [26–28].
These results might provide the possibility of long-term survival of non-vascularized graft
such as pituitary glands or islet cells inside the omental pouch. Another limitation of
the omental pouch is the absence of hypothalamic-pituitary relationship connected with
specialized vascular supply. Accordingly, the implanted pituitary gland may not normally
respond to stress or physiological challenges. The omental pouch might not be considered
a physiological site because some pituitary hormones can be excreted by hepatic clearance.
In particular, GH can be excreted by hepatic clearance, ranging from 50 to 95%. Our
results showed that serum GH levels surged at one week after transplantation, but rapidly
declined over two weeks. This might have been due to hepatic clearance. Serum prolactin
level restored at one week after transplantation and was maintained for five weeks. In the
present study, there was no induced hyperprolactinemia caused by the loss of negative
feedback from the hypothalamus. The mechanism is unclear, but hepatic clearance and
buffering of the hepatic portal system before entering into the systemic circulation might
influence the serum prolactin levels after transplantation of pituitary glands, although the
kidneys are the main site of prolactin elimination [29]. To the best of our knowledge, our
study is the first investigation to implant extracted pituitary glands into the omental pouch.
Because the omental pouch has several limitations, additional investigations to find optimal
site for pituitary transplantation and overcome these limitations are needed. Moreover,
because of the limitations of other sites including the kidney capsule, the ventricle and the
sellar floor as well as the omentum, further studies regarding cell transplantation, such as
stem cell or separated pituitary cells, should be conducted [30,31].
Another limitation of this study was the single time-point measurements of pulsatile
pituitary hormones. For accurate and physiological assessment of pituitary hormones,
multiple blood sampling to discern the basal and pulsatile hormone levels would be
required. However, multiple sampling within a period of hours from the tail vein may
cause considerable stress and can lead to the morbidity and mortality of rats.
5. Conclusions
In this study, it was found that TSH, GH and prolactin were restored one week after
transplantation while ACTH was not released from the graft. In addition, the structural
preservation of implanted hypophysis could be assured by EM and IHC examinations.
In conclusion, this study suggests that transplanted pituitary glands could survive in the
omentum with concomitant partial restoration of anterior pituitary hormones.
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